Summary
This 8-K filing from Becton, Dickinson and Company (BDX), filed on May 16, 2002, reports on a stock option exercise and subsequent sale by a key executive, Deborah J. Neff, President of BD Biosciences. Ms. Neff exercised options to purchase 7,600 shares that were set to expire shortly. To cover associated costs and tax obligations, she sold 3,900 shares on the same day. While a portion of the shares were sold, the net effect of these transactions was an increase in Ms. Neff's direct ownership of BDX shares by 2,700, bringing her total direct holdings to 7,205 shares. This filing also details her additional ownership interests through employee benefit plans, providing a comprehensive view of her stake in the company. Investors can interpret this as a routine transaction for an executive managing stock options, with a net positive increase in their direct shareholding.
Key Highlights
- 1Deborah J. Neff, President of BD Biosciences, exercised options to purchase 7,600 shares of BDX stock.
- 2The exercised options were scheduled to expire on May 17, 2002.
- 3Ms. Neff sold 3,900 shares on May 15, 2002, to cover costs and taxes related to the option exercise.
- 4As a result of these transactions, Ms. Neff's direct ownership of BDX shares increased by a net of 2,700 shares.
- 5Ms. Neff's direct shareholding increased to 7,205 shares following the transactions.
- 6Additional ownership interests are held through BD's Share Incentive Plan (3,091 shares) and Deferred Compensation Plan (1,959 shares).
- 7These transactions were reported via Forms 4 and 144 filed on May 15, 2002.